DeepMed Research

MASSACHUSETTS GENERAL HOSPITAL

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Established: 1811-01-01

Employees: -

Market Cap: -

Website: http://www.massgeneral.org/international

Clinical Trials

Transcranial Direct Current Stimulation Potentiation of Fear Extinction in OCD

Not Applicable

Recruiting

Conditions: Obsessive-Compulsive Disorder

Interventions: Device: Active tDCS
Device: Sham tDCS

First Posted Date: 2022-08-30

Last Posted Date: 2024-07-30

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 120

Registration Number: NCT05521074

Locations: 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States

NLP to Aid in the Evaluation and Diagnosis of FGIDs

Conditions: Functional Gastrointestinal Disorders

First Posted Date: 2022-08-15

Last Posted Date: 2022-08-15

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 700

Registration Number: NCT05501028

Locations: 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States

Psychological Mobile App for Patients With AML

Not Applicable

Terminated

Conditions: Acute Myeloid Leukemia
AML

Interventions: Behavioral: CERENA
Behavioral: DREAMLAND

First Posted Date: 2022-08-15

Last Posted Date: 2023-08-02

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 11

Registration Number: NCT05501171

Locations: 🇺🇸
Duke University, Durham, North Carolina, United States
🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States
🇺🇸
Fred Hutchinson Cancer Research Center, Seattle, Washington, United States

Low-field MRI for Breast Cancer Screening

Not Applicable

Conditions: Malignant Neoplasm of Breast
Breast Benign
Breast Malignant Tumor

Interventions: Device: Magnetic Resonance Imaging (MRI)

First Posted Date: 2022-08-03

Last Posted Date: 2023-09-21

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 40

Registration Number: NCT05486520

Locations: 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States

Genetic Testing Decision Aid

Not Applicable

Recruiting

Conditions: Epithelial Ovarian Carcinoma
Pancreas Adenocarcinoma

Interventions: Behavioral: Electronic Decision Aid
Behavioral: Pre-Test Genetic Counseling

First Posted Date: 2022-07-22

Last Posted Date: 2024-03-04

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 350

Registration Number: NCT05470920

Locations: 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States
🇺🇸
Mass General at North Shore Cancer Center, Danvers, Massachusetts, United States

Culturally Aware AET Non-Initiation Intervention

Not Applicable

Active, not recruiting

Conditions: Breast Cancer
Survivorship
Treatment Adherence
Treatment Refusal
Treatment Compliance

Interventions: Behavioral: Culturally Aware Adjuvant Endocrine Therapy (AET) Non-Initiation Intervention

First Posted Date: 2022-07-19

Last Posted Date: 2025-03-17

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 35

Registration Number: NCT05465408

Locations: 🇺🇸
Massachusetts General Hospital Cancer Center, Boston, Massachusetts, United States
🇺🇸
Dana-Farber Cancer Institute, Boston, Massachusetts, United States
🇺🇸
Dana-Farber Cancer Institute at St Elizabeth's Medical Center, Brighton, Massachusetts, United States

and more 8 locations

Fluoxetine Treatment of Depression in Down Syndrome

Phase 4

Completed

Conditions: Down Syndrome
Depression

Interventions: Drug: Fluoxetine

First Posted Date: 2022-07-14

Last Posted Date: 2025-03-30

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 4

Registration Number: NCT05458479

Locations: 🇺🇸
Lurie Center for Autism, Lexington, Massachusetts, United States

Blood Pressure Monitoring in Postpartum Women at Risk of Hypertension

Not Applicable

Conditions: Hypertension Complicating Pregnancy, Childbirth, and the Puerperium
Chronic Hypertension With Pre-Eclampsia
Hypertension in Pregnancy
Preeclampsia
Gestational Hypertension

Interventions: Behavioral: Remote blood pressure monitoring
Behavioral: Usual Care

First Posted Date: 2022-07-14

Last Posted Date: 2022-07-18

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 200

Registration Number: NCT05457504

Evaluation of Kisspeptin Stimulated Insulin Secretion With Hyperglycemic Clamp

Phase 1

Withdrawn

Conditions: Metabolic Disease

Interventions: Diagnostic Test: Hyperglycemic Clamp
Drug: Kisspeptin-10
Drug: Placebo

First Posted Date: 2022-07-13

Last Posted Date: 2024-08-14

Lead Sponsor: Massachusetts General Hospital

Registration Number: NCT05456854

Locations: 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States

A Pilot Study of Ambulatory Heart Rate Variability Biofeedback for Substance Use Disorder

Not Applicable

Recruiting

Conditions: Substance Use Disorders

Interventions: Device: Heart rate variability biofeedback + treatment as usual
Behavioral: Treatment as usual only

First Posted Date: 2022-07-12

Last Posted Date: 2023-01-10

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 100

Registration Number: NCT05454657

Locations: 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy